Roche
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Switzerland · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Grenzacherstrasse 124, Basel, Basel-Stad...Phone Number
+41616881111Website
www.roche.comRevenue
$79.8 BillionStock Symbol
ROIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
4
3
3
2
1
About Roche
Roche is a global pioneer in pharmaceuticals and diagnostics, dedicated to advancing science to improve people's lives through innovative healthcare solutions. The Swiss-based company operates through two primary divisions: Pharmaceuticals and Diagnostics, making it one of the few healthcare companies with leading positions in both areas. Roche's pharmaceutical division focuses on developing and manufacturing prescription medicines across major therapeutic areas including oncology, immunology, infectious diseases, ophthalmology, and diseases of the central nervous system. The diagnostics division provides a comprehensive range of products and services for early detection, prevention, diagnosis, and management of diseases, spanning laboratory diagnostics, tissue diagnostics, and diabetes care. Roche is committed to personalized healthcare, pioneering the development of targeted therapies and companion diagnostics that enable treatment decisions tailored to individual patients. The compaRead more
Roche Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Roche your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Roche has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Roche is spiking on competitors!
Click to see if Roche had a recent Job posting/layoffs
Earning: See what the market has to say on Roche recently announced quarterly report
Check if Roche has recently received funding, and reach out quickly before it becomes old news!
Roche, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Roche launches new products
Congratulate Masked Content for being promoted to Masked Content at Roche
Recommended Actions
Reach out to Masked Content who joined Roche as Masked Content
Find 3 more new buyers
Compare Similar Companies to Roche
Compare insights from companies similar to Roche, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$4.8B
10K+
Public
$457.7M
1999
Michael BrownExecutive Vice President & Chief Legal Officer & Chief Compliance Officer
Company Profile Activity
Activity Insights
Roche is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Roche is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Roche.
Roche Tech Stack
A closer look at the technologies used by Roche
Most Recent Scoops
Partnership
Partnership, Analytics & Insights, Research & Development, Business Development, Workforce Management, Laboratory Operations, Healthcare Operations, Healthcare Technology, Medical Administration
Earnings
Roche has reported that its top brands Xolair, Hem Libra, Ocrevus, Phesgo, Vabizmo, and Evrysdi collectively generated approximately 1.4 billion Swiss Francs in incremental sales at constant exchange rates in the first half of the year.
Earnings
Roche has provided a HER2 franchise outlook projecting peak sales of approximately 9 billion Swiss Francs (at 2024 constant exchange rates) in 2026, followed by a steady decline to a tail of approximately 4 billion, primarily from Phesgo, with no biosimilar for Perjeta expected in the US before 2028 or the EU before 2027.
Earnings, Finance
Earnings
Roche has reported hematology franchise sales of 4.6 billion Swiss Francs for the first half, growing 14% at constant exchange rates, with Hem Libra delivering strong global growth driven by increasing adoption in non-inhibitor patients and older adults, and has updated its full-year Hem Libra growth outlook to mid single digit from previously low single digit.
Earnings, Finance
Project
Medical Research, Pharmaceuticals, Clinical Operations
Roche News & Media
Genprex partners with Roche Diagnostics on biomarker validation for NSCLC
Validation studies are expected to conclude by the end of 2026, with potential integration into the NSCLC clinical programme thereafter.Roche announces partnership with Ivy Tech to help strengthen Indiana's medical laboratory workforce
Strategic collaboration between Roche Diagnostics and Ivy Tech Community College addresses critical workforce shortages in Indiana's medical laboratory sector through a phased development framework. Phase 1 initiatives include a targeted career awareness campaign and the creation of the...Analyst Report: Roche Holding AG
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Roche
Sign Up For FreeTo access detailed company insights
Roche is a global pioneer in pharmaceuticals and diagnostics, dedicated to advancing science to improve people's lives through innovative healthcare solutions. The Swiss-based company operates through two primary divisions: Pharmaceuticals and Diagnostics, making it one of the few healthcare companies with leading positions in both areas. Roche's p... Read More
